Victory Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.7K | Buy |
32,384
+333
| +1% | +$573 | ﹤0.01% | 2369 |
|
|
2025
Q1 | $107K | Sell |
32,051
-109,429
| -77% | -$364K | ﹤0.01% | 2304 |
|
|
2024
Q4 | $1.05M | Sell |
141,480
-2,800
| -2% | -$20.7K | ﹤0.01% | 1791 |
|
|
2024
Q3 | $1.35M | Buy |
144,280
+115,387
| +399% | +$1.08M | ﹤0.01% | 1645 |
|
|
2024
Q2 | $232K | Sell |
28,893
-64
| -0.2% | -$513 | ﹤0.01% | 2165 |
|
|
2024
Q1 | $429K | Buy |
28,957
+2,036
| +8% | +$30.2K | ﹤0.01% | 2031 |
|
|
2023
Q4 | $219K | Buy |
26,921
+4,323
| +19% | +$35.1K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $103K | Buy |
22,598
+3,937
| +21% | +$17.9K | ﹤0.01% | 2297 |
|
|
2023
Q2 | $131K | Sell |
18,661
-434
| -2% | -$3.06K | ﹤0.01% | 2271 |
|
|
2023
Q1 | $117K | Sell |
19,095
-23,770
| -55% | -$145K | ﹤0.01% | 2338 |
|
|
2022
Q4 | $274K | Sell |
42,865
-99,897
| -70% | -$638K | ﹤0.01% | 2191 |
|
|
2022
Q3 | $1.37M | Sell |
142,762
-42,125
| -23% | -$403K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $2.04M | Sell |
184,887
-38,450
| -17% | -$424K | ﹤0.01% | 1448 |
|
|
2022
Q1 | $3.68M | Sell |
223,337
-69,440
| -24% | -$1.14M | ﹤0.01% | 1348 |
|
|
2021
Q4 | $5.59M | Sell |
292,777
-16,875
| -5% | -$322K | 0.01% | 1302 |
|
|
2021
Q3 | $7.64M | Sell |
309,652
-77,430
| -20% | -$1.91M | 0.01% | 1180 |
|
|
2021
Q2 | $10.1M | Sell |
387,082
-1,513,108
| -80% | -$39.4M | 0.01% | 1127 |
|
|
2021
Q1 | $60.2M | Sell |
1,900,190
-124,764
| -6% | -$3.95M | 0.06% | 461 |
|
|
2020
Q4 | $94M | Sell |
2,024,954
-54,284
| -3% | -$2.52M | 0.1% | 277 |
|
|
2020
Q3 | $68.4M | Sell |
2,079,238
-181,000
| -8% | -$5.96M | 0.09% | 323 |
|
|
2020
Q2 | $62M | Sell |
2,260,238
-1,733,502
| -43% | -$47.6M | 0.08% | 348 |
|
|
2020
Q1 | $120M | Buy |
3,993,740
+1,545,553
| +63% | +$46.3M | 0.1% | 285 |
|
|
2019
Q4 | $67.8M | Buy |
2,448,187
+129,019
| +6% | +$3.57M | 0.08% | 360 |
|
|
2019
Q3 | $42.2M | Buy |
2,319,168
+311,425
| +16% | +$5.67M | 0.05% | 518 |
|
|
2019
Q2 | $49.2M | Sell |
2,007,743
-466,394
| -19% | -$11.4M | 0.1% | 314 |
|
|
2019
Q1 | $23.5M | Sell |
2,474,137
-547,790
| -18% | -$5.21M | 0.05% | 533 |
|
|
2018
Q4 | $26.7M | Buy |
3,021,927
+591,270
| +24% | +$5.23M | 0.07% | 462 |
|
|
2018
Q3 | $27.3M | Buy |
2,430,657
+86,378
| +4% | +$972K | 0.06% | 526 |
|
|
2018
Q2 | $30M | Buy |
2,344,279
+58,780
| +3% | +$752K | 0.06% | 490 |
|
|
2018
Q1 | $38.6M | Buy |
2,285,499
+184,336
| +9% | +$3.12M | 0.08% | 381 |
|
|
2017
Q4 | $16.8M | Sell |
2,101,163
-537,160
| -20% | -$4.3M | 0.04% | 616 |
|
|
2017
Q3 | $20.4M | Buy |
2,638,323
+51,450
| +2% | +$399K | 0.05% | 580 |
|
|
2017
Q2 | $19M | Buy |
2,586,873
+48,390
| +2% | +$356K | 0.04% | 589 |
|
|
2017
Q1 | $18.9M | Buy |
2,538,483
+197,638
| +8% | +$1.47M | 0.05% | 590 |
|
|
2016
Q4 | $16.3M | Buy |
2,340,845
+3,830
| +0.2% | +$26.6K | 0.04% | 614 |
|
|
2016
Q3 | $19.2M | Buy |
+2,337,015
| New | +$19.2M | 0.05% | 565 |
|